Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.

scientific article

Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/NBM.1426
P698PubMed publication ID19650073

P50authorTone F. BathenQ61104171
Ingrid Susann GribbestadQ65706743
Steinar LundgrenQ65706815
Anna M BofinQ88506963
Pål Erik GoaQ92895190
Else M HuuseQ114422035
P2093author name stringLine R Jensen
Tina B Pedersen
P2860cites workTelling cells how to die: docetaxel therapy in cancer cell lines.Q36766382
P433issue1
P921main subjectdocetaxelQ420436
P304page(s)56-65
P577publication date2010-01-01
P1433published inNMR in BiomedicineQ3061252
P1476titleAssessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
P478volume23

Reverse relations

cites work (P2860)
Q48196734Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
Q38712030Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models
Q38989194Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results
Q36134678DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin
Q30687678DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.
Q39995682DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis
Q40309071Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study
Q34101555In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts
Q35497704Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
Q92282846Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells
Q37689772Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
Q39116695Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts
Q30881669MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity.
Q34496670Molecular imaging in cancer treatment
Q34041364Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression
Q57181925Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models
Q35334958Quantitative effects of using compressed sensing in dynamic contrast enhanced MRI
Q35786155Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI
Q38939387[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells